Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2026)

Neuronetics (STIM) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $125.4 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 11.65% year-over-year to $125.4 million in Q1 2026; TTM through Mar 2026 was $547.1 million, a 20.56% increase from a year earlier, with the FY2025 full-year figure at $141.6 million, changed 0.46% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $125.4 million, down from $141.6 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for STIM reached as high as $145.5 million in Q3 2025 and fell as low as $74.1 million in Q3 2024.
• Historically, Liabilities and Shareholders Equity has averaged $118.0 million across 5 years, with a median of $119.2 million in 2022.
• Across the five-year window, Liabilities and Shareholders Equity fell 22.01% in 2023 and surged 96.26% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $116.9 million in 2022, then declined by 0.9% to $115.8 million in 2023, then increased by 21.65% to $140.9 million in 2024, then climbed by 0.46% to $141.6 million in 2025, then dropped by 11.38% to $125.4 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $125.4 million in Q1 2026, $141.6 million in Q4 2025, and $145.5 million in Q3 2025.